Control group:Intravenous infusion

3 trials

Sponsors

Shanghai Sixth People's Hospital, The Affiliated Hospital of Jiangsu University, Affiliated Qingyuan Hospital, Guangzhou Medical University,Qingyuan People's Hospital;

Conditions

Chemotherapy-induced nausea and vomitingOsteosarcomaPostoperative delirium

Phase 3

A multicenter, phase III, randomized, double-blind, placebo-controlled trial for recombinant human anti-PD-L1 monoclonal antibody (ZKAB001) for maintenance therapy after adjuvant chemotherapy in patients with high-grade osteosarcoma

Active, not recruitingChiCTR2000028785

Shanghai Sixth People's HospitalOsteosarcoma

Start: 2020-02-01Updated: 2020-01-06

Phase 4

A Randomized, Open-Label, Parallel-Group Clinical Study to Evaluate the Efficacy and Safety of Aprepitant Injection Administered Twice (on Alternate Days) Versus a Single Dose in Preventing Nausea and Vomiting Induced by Highly Emetogenic Chemotherapy

Active, not recruitingChiCTR2500104533

The Affiliated Hospital of Jiangsu UniversityChemotherapy-induced nausea and vomiting

Start: 2024-09-26Updated: 2025-06-24

Unknown Phase

The Impact of Oliceridine on Postoperative Delirium in Elderly Patients Undergoing Laparoscopic Surgery

Active, not recruitingChiCTR2500106954

Affiliated Qingyuan Hospital, Guangzhou Medical University,Qingyuan People's Hospital;Postoperative delirium

Start: 2025-08-01Updated: 2025-08-18